JP Morgan analysts Atif Rahim, Lisa Gill, and Michael Minchak have initiated coverage on three revenue cycle management (RCM) providers. The existence of this industry is driven by healthcare providers who have complex revenue cycle processes. RCM providers exist because they reduce collection costs and improve revenue yield for healthcare providers.
Accretive Health AH
Overweight, $27 PT
"Accretive is a hospital-focused provider of fully outsourced end-to-end RCM solutions. The company’s offering is unique in the healthcare IT arena as it requires no incremental up-front cost or investment beyond a hospital’s current revenue cycle spend."
AH is currently trading at $13.35.
athenahealth ATHN
Neutral, $34 PT
"athenahealth is a physician-focused provider of RCM services and has established itself as a leader in that market, but the number of new physicians added to its network has slowed recently, which is a concern."
ATHN is currently trading at $25.04.
MedAssets MDAS
Neutral, $32 PT.
"MedAssets is a well-positioned competitor in the
hospital RCM arena, with a vast hospital customer base and competitive product offering, but we believe the recent run in the shares caps the near-term upside."
MDAS is currently trading at $23.41.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Analyst ColorPrice TargetInitiationAtif RahimHealth CareHealth Care ServicesHealth Care TechnologyJP MorganLisa GillMichael Minchak
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in